Search

Search Constraints

You searched for: Author/Creator Assassi, Shervin

Search Results

72. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials. (October 2022)

73. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials. (September 2022)

74. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial. Issue 11 (5th August 2020)

75. Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials. (October 2022)

76. Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis. Issue 11 (28th October 2013)

77. Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis. Issue 11 (28th October 2013)

79. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. (29th September 2022)

80. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Issue 2 (February 2016)